Canada markets open in 3 hours 55 minutes

Satellos Bioscience Inc. (MSCL.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.4300+0.0300 (+7.50%)
At close: 03:25PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 15.47M
Enterprise Value 15.84M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.88
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 6.47

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-39.44%
S&P500 52-Week Change 3-13.08%
52 Week High 31.2000
52 Week Low 30.2200
50-Day Moving Average 30.3520
200-Day Moving Average 30.3681

Share Statistics

Avg Vol (3 month) 347.19k
Avg Vol (10 day) 324k
Shares Outstanding 541.8M
Implied Shares Outstanding 6N/A
Float 834.23M
% Held by Insiders 19.30%
% Held by Institutions 114.41%
Shares Short (Mar 14, 2023) 424.25k
Short Ratio (Mar 14, 2023) 40.73
Short % of Float (Mar 14, 2023) 4N/A
Short % of Shares Outstanding (Mar 14, 2023) 40.06%
Shares Short (prior month Feb 14, 2023) 422.54k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Aug 17, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-39.53%
Return on Equity (ttm)-85.96%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-8.78M
Diluted EPS (ttm)-0.2200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.13M
Total Cash Per Share (mrq)0.08
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.68
Book Value Per Share (mrq)0.20

Cash Flow Statement

Operating Cash Flow (ttm)-5.78M
Levered Free Cash Flow (ttm)-1.88M